Introduction: The Catalyst Clinic's Commitment to Compliance in Peptide Therapy
At The Catalyst Clinic, we understand the importance of compliance with regulatory standards set forth by both the Medicines and Healthcare products Regulatory Agency (MHRA) in the UK and the Food and Drug Administration (FDA) in the United States. Our commitment to adhering to these regulations ensures that our peptide therapies are not only effective but also safe for our patients.By meticulously following the guidelines established by the MHRA and FDA, The Catalyst Clinic emphasizes quality, safety, and efficacy in all aspects of our peptide therapy offerings. This includes strict adherence to Good Manufacturing Practices (GMP), comprehensive clinical trial protocols, and rigorous post-marketing surveillance.We prioritize transparency and excellence in our practices, ensuring that every peptide therapy we provide meets the highest standards set by these regulatory bodies. Our dedication to compliance not only reflects our commitment to patient care but also reinforces our role as a trusted provider in the peptide therapy landscape. At The Catalyst Clinic, we believe that rigorous adherence to regulatory standards is fundamental to delivering innovative and reliable healthcare solutions.
Intervention Sourcing
Pharmaceutical-Grade Compounds. Regulated Sources. No Exceptions.
Every compound discussed and sourced as part of your consultation program at The Catalyst Clinic is obtained exclusively from pharmacies that meet the highest regulatory standards on both sides of the Atlantic. This is not a marketing claim. It is a clinical requirement — and one that the majority of clinics operating in this space do not meet, and will not disclose.
Our sourcing standards
All compounds are sourced from FDA-registered, ISO-9001-certified, GMP-compliant compounding pharmacies in the United States and EMA-regulated compounding pharmacies in Europe. Distribution is managed exclusively through licensed, regulated partners. Every compound arrives with full traceability from synthesis to delivery — batch documentation, independent quality testing, and a verifiable chain of custody.
What pharmaceutical-grade actually means
Pharmaceutical-grade is a verified manufacturing standard, not a marketing descriptor. It means a compound contains precisely what it states on the label — at the stated concentration, free from contaminants, produced under GMP-compliant conditions that are independently audited and fully documented.
The alternative is research-grade compounds sourced from unregistered suppliers. Potency varies between batches. Contaminants that would be rejected in a regulated facility pass undetected. Sterility is unverifiable. For any compound discussed in a clinical context, that standard is not acceptable — and we do not work with suppliers who cannot meet it.
What we will not do
We will not source from any pharmacy that is not FDA-registered or EMA-regulated. We will not discuss compounds we cannot trace to a verified origin. We will not advise on a protocol we cannot support with a documented, compliant supply chain. These are not aspirational standards. They are operational requirements that apply to every patient, every compound, every time.
Why most clinics stay silent on this
Sourcing from regulated pharmacies is more expensive, more logistically complex, and demands ongoing relationships with licensed distribution partners. It is easier — and cheaper — to source from unregulated research chemical suppliers. Many clinics in this space do exactly that, and do not tell their patients.
We consider transparency on sourcing to be a fundamental clinical responsibility. If you are consulting with any clinic about peptide-related programs, ask them directly: where are your compounds sourced? What is the regulatory status of your pharmacy? Can you provide documentation? A clinic that cannot answer those questions clearly should not be advising you.
Regulatory notice
All compounds discussed at The Catalyst Clinic are for research and advisory purposes only. None are licensed medicines under the Human Medicines Regulations 2012 and none are approved by the MHRA for human use in a therapeutic or wellness context. Sourcing from regulated pharmacies reflects our commitment to patient safety and clinical standards — it does not indicate licensed medicinal status under UK law.